Sam Samad - 31 Jan 2024 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)

Reporting relationship: Executive Vice President & CFO
Issuer ticker: DGX
Reported as of: 31 Jan 2024
Net transaction value: +$2,199
SEC form: 4
Accepted by SEC: 02 Feb 2024, 16:38:42 UTC
Prior SEC filing: 26 Oct 2023
Next SEC filing: 16 Feb 2024
Source filing: View source filing
Reporting owner signature: Sean D. Mersten, Attorney in Fact for Sam Samad

Key filing fact

Sam Samad filed Form 4 for QUEST DIAGNOSTICS INC (DGX) on 02 Feb 2024.

Key facts

This page summarizes Sam Samad's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Feb 2024, 16:38.

Change

Previous filing in this sequence was filed on 26 Oct 2023.
Current net transaction value: +$2,199.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DGX transaction

Common Stock

Award

Transaction value: $2,199
Shares: +17
Change %: +0.1%
Price: $129.33
Shares after: 16,510
Date: 31 Jan 2024
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.